AI summary · may contain errors
Pulsed field ablation (PFA) for atrial fibrillation is linked to a 0.36% higher 30-day stroke or TIA risk compared to radiofrequency ablation (RFA) in a high-volume US center.
- 5 cites
Moving in Circulation.
Rebuilt
AI summary · may contain errors
Pulsed field ablation (PFA) for atrial fibrillation is linked to a 0.36% higher 30-day stroke or TIA risk compared to radiofrequency ablation (RFA) in a high-volume US center.
Newest first · last 60 days
AI summary · may contain errors
In pooled adults with acute FXa inhibitor–associated life-threatening hemorrhage treated with andexanet, arterial thrombotic events predict mortality (HR 2.68, 95% CI 1.64–4.36).
AI summary · may contain errors
Aspirin alone after total hip or knee arthroplasty is noninferior to rivaroxaban followed by aspirin for symptomatic venous thromboembolism, with rates of 0.48% vs 0.45%.
AI summary · may contain errors
Left atrial appendage closure (LAAC) RCTs in atrial fibrillation are heterogeneous, so pooled estimates may not apply to a single patient group or decision.
AI summary · may contain errors
Three months of DOAC therapy after TAVR reduced hypoattenuated leaflet thickening (HALT) at 3 months versus lifelong single antiplatelet therapy, 12.1% vs 31.8%.
AI summary · may contain errors
In 5213 patients with acute pulmonary embolism, major bleeding occurred in 3.1% within 30 days, with 78 early (<7 days) and 81 late (≥7 days) events.
AI summary · may contain errors
A 30-year-old man with Ebstein anomaly was diagnosed with pre-excited atrial fibrillation, showing a fast, broad, irregular electrocardiography pattern.
AI summary · may contain errors
An octogenarian case with multiple comorbidities presented to the emergency department with weakness and anorexia, and was diagnosed with atrial fibrillation showing a very regular rhythm.
AI summary · may contain errors
Selective blockade of miR-31-5p–CALCR binding in mice with established atrial remodeling reverses atrial fibrosis and reduces atrial arrhythmia burden.
AI summary · may contain errors
In EPIDAURUS, a 1-month DOAC plus potent P2Y12 inhibitor regimen (prasugrel or ticagrelor) in atrial fibrillation plus acute coronary syndrome was linked to higher bleeding rates in 602 enrolled patients.
AI summary · may contain errors
In the ANNEXa-I trial cohort of 434 patients with factor Xa inhibitor–associated intracerebral hemorrhage, hematoma expansion occurred in 31.8% and was linked to specific NCCT markers.
AI summary · may contain errors
CLOSURE-AF and CHAMPION-AF results should guide whether left atrial appendage occlusion is chosen over direct oral anticoagulants for left atrial appendage occlusion in atrial fibrillation.
AI summary · may contain errors
In nonvalvular atrial fibrillation, percutaneous left atrial appendage closure (LAAC) shows similar overall stroke rates versus oral anticoagulation (OR 1.10, 95% CI 0.78–1.56).
AI summary · may contain errors
In ASAP-TOO, left atrial appendage closure with a Watchman device achieved 97.8% implantation success and a 1.0% primary safety event rate through 5 years in OAC-unsuitable atrial fibrillation patients.
AI summary · may contain errors
In patients with atrial fibrillation and prior ischemic stroke, apixaban significantly reduced both any stroke (RR 0.72, 95% CI 0.53–0.97) and major bleeding (RR 0.73, 95% CI 0.54–0.99) versus warfarin.
AI summary · may contain errors
In high-risk atrial fibrillation patients from two randomized trials (1,290 participants), percutaneous left atrial appendage closure showed no statistically significant difference vs medical therapy for stroke/systemic embolism/cardiovascular death (adjusted HR 0.98).
AI summary · may contain errors
High composite inflammatory burden on admission is linked to higher 90-day ischemic events after breakthrough ischemic stroke in ASPERA-R, with a hazard ratio of 1.53.
AI summary · may contain errors
In the RENOVE trial’s extended anticoagulation period, clinically relevant bleeding was 11.7% with rivaroxaban versus 13.7% with apixaban, with adjusted HR 0.90.
Journals this month
Topics moving, week to 17 Nov 2026
By field